Incidence and Clinical Outcome of Hypophosphatemia in Pediatric Burn Patients

Heitor Pons Leite1, Larissa Araújo Pinheiro Nogueira, Ariane Helena Calassa Teodosio

  • 1From the *Department of Pediatrics, Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil; and †Discipline of Nutrition and Metabolism, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.

Insights

In pediatric burn patients, low serum phosphate (hypophosphatemia) is common and linked to worse outcomes. This condition significantly decreases intensive care unit discharge probability and prolongs mechanical ventilation duration.

Area of Science:

  • Pediatric critical care medicine
  • Burn injury management
  • Clinical chemistry

Background:

  • Serum phosphate levels are crucial for cellular function.
  • Severely burned children face complex physiological challenges.
  • The impact of hypophosphatemia on outcomes in pediatric burn patients requires further elucidation.

Purpose of the Study:

  • To investigate factors associated with serum phosphate concentrations in severely burned children.
  • To determine if hypophosphatemia correlates with adverse clinical outcomes in this population.

Main Methods:

  • Retrospective analysis of 78 severely burned children admitted to the intensive care unit (ICU).
  • Generalized estimating equations used to assess factors influencing serum phosphate over the first 10 ICU days.
  • Competing-risk analysis applied to evaluate ICU discharge probability and time on mechanical ventilation.

Main Results:

  • A high incidence of hypophosphatemia (79.5%) was observed.
  • Serum phosphate concentrations correlated negatively with C-reactive protein, indicating a link to inflammation.
  • Hypophosphatemia independently reduced the probability of ICU discharge by 68% and increased mechanical ventilation duration by 2.9 days.

Conclusions:

  • Serum phosphate levels in pediatric burn patients are associated with the inflammatory response.
  • Hypophosphatemia is a significant independent predictor of poorer outcomes, including lower ICU discharge rates and prolonged mechanical ventilation.
  • Monitoring and management of phosphate levels may be critical in optimizing care for severely burned children.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
891
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
647
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.7K